CARDIOVASCULAR CATHETERS AND SYSTEMS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Cardiovascular Catheters and Systems in Millions of US$. The major product segments analyzed are Diagnostic Catheters (Angiography Catheters, & Electrophysiology (EP) Mapping Catheters), and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, Electrophysiology (EP) Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed-wire Catheters, & Guide Catheters). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 81 companies including many key and niche players such as -

Abbott Laboratories
Boston Scientific
C.R. Bard, Inc.
Cardima, Inc.
CryoCath Technologies Inc.
Edwards Lifesciences Corporation


Click here to request a full list of companies covered in the report...

Code: MCP-3206
Price: $3950
Companies: 81
Pages: 481
Date: April 2008
Market Data Tables: 171

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   A. Diagnostic Catheters.....I-4
Angiography Catheters.....I-4
Electrophysiology (EP) Mapping Catheters.....I-4
B. Therapeutic Catheters.....I-4
Rapid -Exchange PTCA Balloon Catheter.....I-4
Over-The-Wire PTCA Balloon Catheter.....I-4
  
   Electrophysiology Ablation Catheters.....I-5
Atherectomy Catheters.....I-5
Perfusion and Fixed Balloon Catheters.....I-5
Guide Catheters.....I-5
  
   Technological Advancements to Drive Growth.....II-1
Worldwide Cardiovascular Catheters Market.....II-1
1$100
   Market Trends & Issues.....II-2
Lack of Pharmacological Alternatives Boost Demand for Cardiovascular Catheters.....II-2
Energy-Based Solutions Compete with Conventional Interventional Systems.....II-2
Repeat Interventional Procedures Affected by the Advent of Drug-Eluting Stents.....II-2
1$100
   RF Catheter Ablation Gains Popularity.....II-3
Molding Material and Technology.....II-3
Diagnostic Catheters – Advance from the Workhorse 8 Fr.....II-3
Smaller the Better.....II-3
1$100
   PTCA Catheters – Affected by Direct Stenting.....II-4
Angioplasty – Under Price Pressure.....II-4
Restenosis – The Unsolved Problem.....II-4
New Pharmacological Therapies – Minimizing the Need for Interventional
  Procedures?.....II-4
2$200
   Cardiovascular Catheters – Highly Concentrated Market.....II-6
Table 1: Leading Players in Global Angioplasty / Angiography Catheter Market (2004 & 2005E): Percentage Breakdown of Value Sales for Boston Scientific Johnson & Johnson, Guidant, Medtronic, and Others (includes corresponding Graph/Chart).....II-6
1$400
   Table 2: Leading Players in Global Guide Catheters Market (2004 & 2005): Percentage Breakdown of Value Sales for Johnson & Johnson, Boston Scientific, Guidant, Medtronic and Others (includes corresponding Graph/Chart).....II-7

Table 3: Leading Players in Global Electrophysiology (EP) Catheter (Mapping and Ablation) Market (2004 & 2005): Percentage Breakdown of Value Sales for Johnson & Johnson, St. Jude Medical, Boston Scientific,C.R.Bard and Others (includes corresponding Graph/Chart).....II-7
1$400
   Balloon Catheters.....II-8
Table 4: Leading Players in Global Balloon Catheter Market (2004 & 2005): Percentage Breakdown of Value Sales for Boston Scientific, Guidant, Medtronic, Johnson & Johnson and Others (includes corresponding Graph/Chart).....II-8
1$400
   Historical Perspective.....II-9
Cardiac Catheterization: Most Accurate of all Cardiac Diagnostic Examinations.....II-9
1$100
   Catheters.....II-10
Designing of Specialized Catheters.....II-10
Factors Determining Competitiveness.....II-10
Preventing Infection.....II-10
Catheter Related Infections.....II-10
Flow and Sealing Capability.....II-10
1$100
   Safety.....II-11
System Suitability and Comprehensiveness.....II-11
Ease of Insertion.....II-11
Maneuverability.....II-11
Cardiovascular Catheters – Product Group/Segment Overview.....II-11
1$100
   A. Diagnostic Catheters.....II-12
Angiography Catheters.....II-12
Electrophysiology (EP) Mapping Catheters.....II-12
Purpose.....II-12
1$100
   Scope of Electrophysiology Studies.....II-13
Precaution.....II-13
B. Therapeutic Catheters.....II-13
Catheters Designed for Therapeutic Procedures.....II-13
Angioplasty: Where is it Used?.....II-13
Types of Angioplasty.....II-13
1$100
   Percutaneous Transluminal Coronary Angioplasty or PTCA.....II-14
PTCA Catheters.....II-14
Types of Balloon Catheters.....II-14
Rapid -Exchange PTCA Balloon Catheter.....II-14
1$100
   Over-The-Wire PTCA Balloon Catheter.....II-15
Electrophysiology Ablation Catheters.....II-15
1$100
   Atherectomy Catheters.....II-16
Perfusion and Fixed Balloon Catheters.....II-16
Guide Catheters.....II-16
1$100
   Heart – Historic Facts and Figures.....II-17
Table 5: Number of Deaths from Circulatory Disorders Worldwide by Region (2002) (in ‘000) (includes Corresponding Graph/Chart).....II-17
Interventional Cardiology.....II-17
1$400
   PTCRA – The procedure.....II-18
Interventional Cardiology Market in the US & Europe – A Comparison.....II-18
1$100
   Radiation Therapy (Brachytherapy).....II-19
An Insight into Cardio Vascular Diseases.....II-19
Coronary Artery Disease (CAD).....II-19
Definition.....II-19
Causes and Symptoms.....II-19
1$100
   Major Risk Factors.....II-20
Non-Controllable Risk Factors.....II-20
Heredity.....II-20
Sex.....II-20
Age.....II-20
Controllable Risk Factors.....II-20
Treatment.....II-20
1$100
   Angina Pectoris.....II-21
Arrhythmias.....II-21
Atrial Fibrillation – A Common Arrhythmia.....II-21
1$100
   More in Women.....II-22
Stroke.....II-22
Congestive Heart Failure.....II-22
Key Terms (For Reference).....II-22
Angina.....II-22
1$100
   Aneurysms.....II-23
Angiography.....II-23
Angioplasty.....II-23
Aortic Valve.....II-23
Atherosclerosis.....II-23
Bradycardia.....II-23
Catheter.....II-23
Coronary Arteries.....II-23
Echocardiogram.....II-23
Electrocardiogram.....II-23
Electrophysiology (EP) study.....II-23
1$100
   Pacemaker.....II-24
Plaque.....II-24
HDL Cholesterol.....II-24
LDL Cholesterol.....II-24
Stenosis.....II-24
Stroke.....II-24
Tachycardia.....II-24
1$100
   US-Based Inventors Granted Patent for Perfusion Balloon Angioplasty Catheter.....II-25
California Scientists Create Intravascular Balloon Catheters for Angioplasty
  Procedures.....II-25
Minnesota Scientists Develop New Ablation Catheter.....II-25
American Inventor Devises Drug Delivery Balloon Catheter.....II-25
US-Based Inventors Create Atherectomy Catheter.....II-25
1$100
   US-Based Inventors Develop Atherectomy Device for Treatment of Occlusions.....II-26
US-Based Inventor Creates New Ablation Catheter System.....II-26
Japanese Inventor Creates RF Thermal Balloon Catheter.....II-26
1$100
   Stereotaxis Obtains FDA Approval for 8mm Magnetic Ablation Catheter.....II-27
ClearStream Gains FDA Approval for PTA Angioplasty Balloon Catheters.....II-27
AngioSculpt® Gains Japanese Approval for AngioSculpt® Catheter.....II-27
Cordis Introduces Fire Star Rx and Dura Star Rx Catheters.....II-27
1$100
   Cordis Introduces AVIATOR™ Catheter.....II-28
FlowCardia Introduces CROSSER Catheter Product Line.....II-28
Medtronic’s Sprinter® Catheter Gains CE Mark Approval.....II-28
St. Jude Gains CE Mark & FDA Approvals for Therapy™ Cool Path™ Catheter.....II-28
1$100
   FDA Clears Venture™ Catheter Use with Rapid Exchange Delivery Platform.....II-29
Eurocor Unveils DIOR Catheter in Germany.....II-29
FDA Approves InnerChange Micro-Introducer Catheter.....II-29
Stereotaxis Gains EU Approval Magnetic Irrigated Ablation Catheter.....II-29
Atrium Medical Obtains CE Mark for ClearWay™ RX Catheter.....II-29
1$100
   Lumen Gains FDA Approval for Large Sized Xtract™ Catheters.....II-30
Opto Circuits Achieves CE Mark Approval for its Catheter.....II-30
FDA Approves Abiomed’s Impella 5.0 Catheter-Based Circulatory Support Systems.....II-30
1$100
   Medical Ventures Gains CE Mark Approval for Metricath Gemini® Balloon-Catheter.....II-31
St. Jude Receives Regulatory Approval for its Safire Ablation & Inquiry Optima Plus
  Catheters.....II-31
Boston Scientific Introduces Sterling™ Monorail® Balloon Dilatation Catheter.....II-31
St. Jude Receives Approval to Market EnSite® System in Japan .....II-31
Merit Medical’s Impress Diagnostic Catheter Gains CE Mark & FDA Approvals.....II-31
1$100
   Medtronic Gains FDA Approval for Export® XT spiration Catheter.....II-32
Medtronic Obtains CE Mark Approval to Market Melody™ and Ensemble™ System.....II-32
Boston Scientific Gains FDA Approval for its Rio™ Aspiration Catheter.....II-32
Possis Introduces AngioJet® Spiroflex®Rheolytic Thrombectomy Catheter.....II-32
1$100
   Boston Scientific Launches Chilli II Cooled Ablation Catheter.....II-33
Terumo Introduces PTCA Catheter with the Smallest Diameter.....II-33
Japan Lifeline Introduces OTTIMO ROSSO Balloon atheter for PTCA Procedures.....II-33
FDA Clears St. Jude’s Therapy™ EP & IBI-1500T6 Cardiac Ablation Generator
  Catheters.....II-33
Terumo Introduces Heartrail II PTCA Guiding Catheter.....II-33
1$100
   FDA Grants Approval to Alliance for Reprocessing AcuNav™ Ultrasound Catheter.....II-34
Cook Introduces New ATB® PTA Dilatation Catheter.....II-34
St. Jude Unveils New Venture™ Wire Control Catheter Across the United States.....II-34
Possis Medical Adds Two New Catheters to its AngioJet® Rheolytic™ Thrombectomy
  Line.....II-34
Cook Introduces CODA for Endovascular Market.....II-34
1$100
   Spectranetics Develops Laser Catheter for Peripheral Vascular Disease.....II-35
Medrad Inc Introduces Avanta™ Fluid Management Injection System and Vanguard Dx™
  Angiographic Catheter.....II-35
Medtronic Releases Medtronic Attain Select 6238 TEL Guide Catheter.....II-35
AngioScore Receives CE Mark Approval for its AngioSculpt Scoring Balloon
  Catheter.....II-35
1$100
   Spectranetics Introduces New Catheters.....II-36
Guidant Corporation Unveils VOYAGER™ Coronary Dilatation Catheter.....II-36
Medtronic Introduces Two New Catheters.....II-36
1$100
   Micrus Enters into Agreement with Genesis.....II-37
Teleflex Acquires Arrow International.....II-37
FoxHollow Merges with ev3.....II-37
1$100
   J&J Bags Marketing Rights for Topspin’s Catheter.....II-38
Cordis to Market ClearStream Technologies’ Catheters.....II-38
Relisys to Establish Catheter Production Facility in India.....II-38
Boston Scientific Acquires Guidant.....II-38
1$100
   Abbott Acquires Guidant’s Vascular Business.....II-39
Cordis in Distribution Agreement with Brivant.....II-39
Cordis Enters into Definitive Agreement to Distribute ClearStream’s PTCA Balloon
  Catheter.....II-39
1$100
   St. Jude and GE Healthcare Collaborate to Develop Advanced Technologies for Cardiac
  Procedures.....II-40
Bard Acquires Venetec International.....II-40
Koninklijke Philips Takes Over Witt Biomedical.....II-40
FoxHollow Enters into Definitive Agreement to Acquire Kerberos.....II-40
Biosense Recieves Expanded Indication for NAVISTAR® THERMOCOOLÒ Catheter for
  Treatment of Ventricular Tachycardia.....II-40
Hansen Medical Completes Clinical Trial for Sensei Robotic Catheter System.....II-40
1$100
   Biosense and Siemens Enter into Strategic Alliance Involving Catheters.....II-41
Recom Inks MOU with TZ Medical to Develop Cardiac Catheters.....II-41
Cordis Takes Over LuMend.....II-41
1$100
   Hansen Medical Enters into Cross-Licensing Agreement with Intuitive Surgical.....II-42
Hansen Medical Acquires Intellectual Assets of endoVia Medical.....II-42
Micrus Takes Over VascularFX.....II-42
St. Jude Medical Acquires Endocardial Solutions.....II-42
St. Jude Medical Acquires Velocimed.....II-42
1$100
   FlowCardia Bags European Approval for Crosser Catheter.....II-43
AVI BioPharma Regains Full Control on Resten-NG Antisense Therapy.....II-43
Boston Scientific Acquires Precision Vascular Systems.....II-43
Edwards Lifesciences Acquires PVT.....II-43
St. Jude Medical Acquires IBI.....II-43
1$100
   St. Jude Medical Takes Over Epicor Medical.....II-44
Merit Medical Systems Inks an Agreement with Novation.....II-44
Rochester Medical Enters into a Supply Agreement with Hollister.....II-44
CardioTech International Enters into a Licensing Agreement with BAS.....II-44
CryoCor’s Model 1200 Cardiac Catheter Series Receives FDA Clearance.....II-44
CryoCath’s Freezor MAX Catheter Device Receives FDA Clearance.....II-44
1$100
   LubriLAST™-coated Catheters Receives MOHLW Clearance.....II-45
Abbott Laboratories Acquires Assets of JOMED.....II-45
JOMED Sells IVUS and Functional Management Business to Volcano Therapeutics.....II-45
Boston Scientific in Alliance with Corautus Genetics.....II-45
Mogul Obtains FDA Approval for Diagnostic Catheters.....II-45
1$100
   Abbott Laboratories (USA).....II-46
Boston Scientific (USA).....II-46
1$100
   C.R. Bard, Inc. (USA).....II-47
Cardima, Inc. (USA).....II-47
CryoCath Technologies Inc. (Canada).....II-47
1$100
   Edwards Lifesciences Corporation (USA).....II-48
EP Medsystems (USA).....II-48
Johnson & Johnson (USA).....II-48
1$100
   Cordis Corporation (USA).....II-49
Biosense Webster (USA).....II-49
1$100
   Medtronic (USA).....II-50
Merit Medical Systems, Inc. (USA).....II-50
1$100
   St. Jude Medical (USA).....II-51
Endocardial Solutions, Inc. (USA).....II-51
1$100
   Teleflex Medical (USA).....II-52
Terumo Medical Corporation (Japan).....II-52
1$100
   Table 6: World Recent Past, Current & Future Analysis for Cardiovascular Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-531$400
   Table 7: World Long-term Projections for Cardiovascular Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-541$400
   Table 8: World 10-Year Perspective for Cardiovascular Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-551$400
   Table 9: World Recent Past, Current & Future Analysis for Diagnostic Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includescorresponding Graph/Chart).....II-561$400
   Table 10: World Long-term Projections for Diagnostic Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-571$400
   Table 11: World Recent Past, Current & Future Analysis for Diagnostic Catheters by Product Segment – Angiography Catheters and EP Mapping Catheters Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-58

Table 12: World Long-term Projections for Diagnostic Catheters by Product Segment – Angiography Catheters & EP Mapping Catheters Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-58
1$400
   Table 13: World 10-Year Perspective for Diagnostic Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-59

Table 14: World 10-Year Perspective for DiagnosticcCatheters by Product Segment – Percentage Breakdowncof Dollar Sales for Angiography Catheters and EP Mapping Catheters Markets for Years 2003, 2008 & 2012.....II-59
1$400
   Table 15: World Recent Past, Current & Future Analysis for Angiography Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzedcwith Annual Sales Figures in US$ Million forcYears 2000 through 2010 (includes corresponding Graph/Chart).....II-601$400
   Table 16: World Long-term Projections for Angiography Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-611$400
   Table 17: World 10-Year Perspective for Angiography Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe,Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-621$400
   Table 18: World Recent Past, Current & Future Analysis for EP Mapping Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-631$400
   Table 19: World Long-term Projections for EP Mapping Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-641$400
   Table 20: World 10-Year Perspective for EP Mapping Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-651$400
   Table 21: World Recent Past, Current & Future Analysis for Therapeutic Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-661$400
   Table 22: World Long-term Projections for Therapeutic Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-671$400
   Table 23: World Recent Past, Current & Future Analysis for Therapeutic Catheters by Product Segment – Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-68

Table 24: World Long-term Projections for Therapeutic Catheters by Product Segment – Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-68
1$400
   Table 25: World 10-Year Perspective for Therapeutic Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-691$400
   Table 26: World 10-Year Perspective for Therapeutic Catheters by Product Segment – Percentage Breakdown of Dollar Sales for Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-701$400
   Table 27: World Recent Past, Current & Future Analysis for Rapid-Exchange PTCA Balloon Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-711$400
   Table 28: World Long-term Projections for Rapid-Exchange PTCA Balloon Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-721$400
   Table 29: World 10-Year Perspective for Rapid-Exchange PTCA Balloon Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-731$400
   Table 30: World Recent Past, Current & Future Analysis for Over-the-Wire PTCA Balloon Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-741$400
   Table 31: World Long-term Projections for Over-the-Wire PTCA Balloon Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-751$400
   Table 32: World 10-Year Perspective for Over-the-Wire PTCA Balloon Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-761$400
   Table 33: World Recent Past, Current & Future Analysis for EP Ablation Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-771$400
   Table 34: World Long-term Projections for EP Ablation Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-781$400
   Table 35: World 10-Year Perspective for EP Ablation Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-791$400
   Table 36: World Recent Past, Current & Future Analysis for Atherectomy Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-801$400
   Table 37: World Long-term Projections for Atherectomy Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-811$400
   Table 38: World 10-Year Perspective for Atherectomy Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-821$400
   Table 39: World Recent Past, Current & Future Analysis for Perfusion and Fixed Balloon Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-831$400
   Table 40: World Long-term Projections for Perfusion and Fixed Balloon Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-841$400
   Table 41: World 10-Year Perspective for Perfusion and Fixed Balloon Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-851$400
   Table 42: World Recent Past, Current & Future Analysis for Guide Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-861$400
   Table 43: World Long-term Projections for Guide Catheters by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-871$400
   Table 44: World 10-Year Perspective for Guide Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-881$400
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Cardiovascular Catheters Market.....III-1
Competition.....III-1
1$75
   Table 45: Leading Players in the US Cardiovascular Catheters Market (2005): Percentage Breakdown of Value Sales for Boston Scientific, Cordis (J&J), Guidant Corporation, Medtronic, and Others (includes corresponding Graph/Chart).....III-21$250
   Arrhythmia Management Products.....III-3
Cardiovascular Disease in the US – An Insight.....III-3
1$75
   Table 46: Prevalence of Cardiovascular Disease in the US: 2004 (Includes Corresponding Graph/Chart).....III-4
Market Trends and Issues.....III-4
Rising Obesity Rates & Numbers Lead to Increased Number of Interventional Cardiac
  Procedures.....III-4
Reimbursements – A Major Issue Affecting Growth in Cardiovascular Devices
  Market.....III-4
Need for Advanced Cardiovascular Devices at Competitive Prices.....III-4
1$250
   Inadequate Clinical Evidence Deters Surgeons from Adopting New Catheters.....III-5
Increasing Demand for Atherectomy & Thrombectomy Products.....III-5
Need for Improvement in Hypotube Design.....III-5
Reimbursement Rates in the US.....III-5
Table 47: Common Physician Payments for Percutaneous Coronary Interventions.....III-5
1$250
   Table 48: Common Outpatient Ambulatory Procedure classifications (APCs) for Percutaneous Coronary Interventions.....III-6

Table 49: Medicare Physician Professional Payment.....III-6

Table 50: Payment for Carotid Artery Stenting.....III-6
Payment for Peripheral Interventions.....III-6
Table 51: Hospital In-patient Payment.....III-6

Table 52: Hospital Outpatient – Based on APCClassification.....III-6
1$250
   Table 53: Physician Professional Payment – Based on CPT® Code.....III-7

Table 54: Peripheral Stent / Shunt Placement, Percutaneous.....III-7

Table 55: Catheter Placement.....III-7
1$250
   Table 56: Diagnostic Angiography, Radiological S&I.....III-8

Table 57: Procedural Radiological S&I.....III-8
1$250
   Product Launches/ Approvals/Patents.....III-97$375
   Strategic Developments.....III-168$425
   Key Players.....III-24
Abbott Laboratories.....III-24
Boston Scientific Corporation.....III-24
1$75
   C.R. Bard, Inc......III-25
Cardima, Inc......III-25
1$75
   Cardiofocus, Inc......III-26
Edwards Lifesciences Corporation.....III-26
1$75
   EP Medsystems.....III-27
Johnson & Johnson.....III-27
Cordis Corporation.....III-27
1$75
   Biosense Webster.....III-28
Medtronic, Inc......III-28
1$75
   Merit Medical Systems, Inc......III-29
Spectranetics Corporation.....III-29
St. Jude Medical.....III-29
1$75
   Endocardial Solutions, Inc......III-30
Teleflex Medical.....III-30
2$150
   B. Market Analytics.....III-32
Table 58: US Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-32
1$250
   Table 59: US Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-331$250
   Table 60: US 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-34
1$250
   A. Market Analysis.....III-35
Current & Future Analysis.....III-35
Key Player.....III-35
CryoCath Technologies, Inc......III-35
1$75
   B. Market Analytics.....III-36
Table 61: Canadian Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion & Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-36
1$250
   Table 62: Canadian Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon,& Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-371$250
   Table 63: Canadian 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-38
1$250
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
PTCA Catheter Market.....III-39
Product Launches/Developments.....III-39
2$150
   Key Players.....III-41
Japan Lifeline Co., Ltd......III-41
Terumo Medical Corporation.....III-41
Tokai Medical Products Co., Ltd......III-41
1$75
   B. Market Analytics.....III-42
Table 64: Japanese Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters,Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-42
1$250
   Table 65: Japanese Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion & Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million forYears 2011 through 2015 (includes corresponding Graph/Chart).....III-431$250
   Table 66: Japanese 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-44
1$250
   A. Market Analysis.....III-45
Current & Future Analysis.....III-45
European Union Cardiovascular Diseases Fact Sheet.....III-45
1$75
   Angioplasty Products Market.....III-46
Trends Observed in Various Countries.....III-46
Product Launches/Developments.....III-46
2$150
   Strategic Corporate Developments.....III-482$150
   B. Market Analytics.....III-50
Table 67: European Recent Past, Current & Future Analysis for Cardiovascular Catheters by Geographic Region – France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-50

Table 68: European Long-term Projections for Cardiovascular Catheters by Geographic Region – France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-50
1$250
   Table 69: European Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-511$250
   Table 70: Canadian Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion & Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Millionfor Years 2011 through 2015 (includescorresponding Graph/Chart).....III-521$250
   Table 71: European 10-Year Perspective for Cardiovascular Catheters by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-531$250
   Table 72: European 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 and 2012 (includes corresponding Graph/Chart).....III-54
1$250
   A. Market Analysis.....III-55
Current & Future Analysis.....III-55
EP Catheters Market.....III-55
1$75
   B. Market Analytics.....III-56
Table 73: French Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-56
1$250
   Table 74: French Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-571$250
   Table 75: French 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-58
1$250
   A. Market Analysis.....III-59
Current & Future Analysis.....III-59
Electrophysiology Market Overview.....III-59
Competitive Scenario.....III-59
1$75
   B. Market Analytics.....III-60
Table 76: German Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-60
1$250
   Table 77: German Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-611$250
   Table 78: German 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-62
1$250
   A. Market Analysis.....III-63
Current & Future Analysis.....III-63
Electrophysiology Market Overview.....III-63
1$75
   B. Market Analytics.....III-64
Table 79: Italian Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-64
1$250
   Table 80: Italian Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-651$250
   Table 81: Italian 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-66
1$250
   A. Market Analysis.....III-67
Current & Future Analysis.....III-67
Healthcare Industry.....III-67
UK Cardiovascular Diseases Fact Sheet.....III-67
1$75
   B. Market Analytics.....III-68
Table 82: UK Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-68
1$250
   Table 83: UK Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-691$250
   Table 84: UK 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-70
1$250
   A. Market Analysis.....III-71
Current & Future Analysis.....III-71
Spain.....III-71
Electrophysiology Market.....III-71
Outlook.....III-71
1$75
   B. Market Analytics.....III-72
Table 85: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/ Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-72
1$250
   Table 86: Rest of Europe Long-term Projections for Cardiovascular Catheters by Product Group/ Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-731$250
   Table 87: Rest of Europe 10-Year Perspective for Cardiovascular Catheters by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 and 2012(includes corresponding Graph/Chart).....III-74
1$250
   A. Market Analysis.....III-75
Current & Future Analysis.....III-75
Increasing Rate of Western Diseases.....III-75
Focus on Select Markets.....III-75
Australia.....III-75
1$75
   China.....III-76
Treatment Providers and Hospitals Overview.....III-76
India.....III-76
Market Overview.....III-76
1$75
   Strategic Corporate Developments.....III-771$75
   B. Market Analytics.....III-78
Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion & Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-78
1$250
   Table 89: Asia-Pacific Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon,and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includescorresponding Graph/Chart).....III-791$250
   Table 90: Asia-Pacific 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-80
1$250
   Market Analysis.....III-811$75
   Current & Future Analysis.....III-82
Table 91: Latin American Recent Past, Current & Future Analysis for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) & Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters,Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-82
1$250
   Table 92: Latin American Long-term Projections for Cardiovascular Catheters by Product Group/Segment – Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-831$250
   Table 93: Latin American 10-Year Perspective for Cardiovascular Catheters by Product Group/Segment – Percentage Breakdown of Dollar Sales for Diagnostic Catheters (Angiography Catheters and EP Mapping Catheters) and Therapeutic Catheters (Rapid-Exchange PTCA Balloon Catheters, Over-The-Wire PTCA Balloon Catheters, EP Ablation Catheters, Atherectomy Catheters, Perfusion and Fixed Balloon, and Guide Catheters)Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-841$250
  
Total Companies Profiled: 64 (including Divisions/Subsidiaries - 89)

Region/Country Players

The United States 39 Canada 4 Japan 2 Europe 39 France 2 Germany 12 The United Kingdom 2 Italy 1 Spain 1 Rest of Europe 21 Asia-Pacific (Excluding Japan) 5
Click here to request a full table of contents and more details on this project.